nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

22.09.2016 | Original Paper

Childhood hyperactivity and mood problems at mid-life: evidence from a prospective birth cohort

verfasst von: Jenny Stuart-Smith, Anita Thapar, Barbara Maughan, Ajay Thapar, Stephan Collishaw

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Childhood hyperactivity leads to mental health problems, but it is not known whether there are long-term risks for adult mood problems in unselected population cohorts that extend to mid-life. Aims were to examine links between childhood hyperactivity and mood problems up to age 50 years and to consider confounding factors and gender differences in associations.

Methods

The National Child Development Study (NCDS) is a UK cohort of children born in 1958. Children with (N = 453) and without (N = 9192) pervasive and persistent hyperactivity were followed to age 50. Adult mood was assessed using the Malaise Inventory at ages 23, 33, 42, and 50 years and the CIS-R interview at 45 years.

Results

Childhood hyperactivity predicted low mood at all adult assessments (ES = 0.27–0.45), including after covariate adjustment (childhood adversity, emotional and behavioural problems, and attainment).

Conclusion

Hyperactivity has enduring risk effects on low mood throughout the life course that extend to middle age.

Nur mit Berechtigung zugänglich

Thapar A, Cooper M (2016) Attention deficit hyperactivity disorder. Lancet 387:1240–1250CrossRefPubMed

Thapar A, Cooper M, Jefferies R, Stergiakouli E (2012) What causes attention deficit hyperactivity disorder? Arch Dis Child 97:260–265CrossRefPubMed

Cherkasova M, Sulla EM, Dalena KL, Pondé MP, Hechtman L (2013) Developmental course of attention deficit hyperactivity disorder and its predictors. J Can Acad Child Adolesc Psychiatry 22:47–54CrossRefPubMedPubMedCentral

Wilens TE, Biederman J, Spencer TJ (2002) Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 53:113–131CrossRefPubMed

Polanczyk GV, Willcott EG, Salum GA, Kieling C, Rohde LA (2014) ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 43:434–442CrossRefPubMedPubMedCentral

Antshel KM, Hargrave TM, Simonescu M, Kaul P, Hendricks K, Faraone SV (2011) Advances in understanding and treating ADHD. BMC Med 9:72CrossRefPubMedPubMedCentral

Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, Castellanos FX (2012) Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69:1295–1303CrossRefPubMedPubMedCentral

Langley K, Fowler T, Ford T, Thapar AK, van den Bree M, Harold G, Owen MJ, O’Donovan MC, Thapar A (2010) Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 196:235–240CrossRefPubMed

Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV (2006) Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 36:167–179CrossRefPubMed

10.

Bussing R, Mason DM, Bell L, Porter P, Garvan C (2010) Adolescent outcomes of childhood attention-deficit/hyperactivity disorder in a diverse community sample. J Am Acad Child Adolesc Psychiatry 49:595–605PubMedPubMedCentral

11.

Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE (2012) A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 10:99CrossRefPubMedPubMedCentral

12.

Able SL, Johnston JA, Adler LA, Swindle RW (2007) Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 37:97–107CrossRefPubMed

13.

Thapar A, Collishaw S, Pine DS, Thapar AK (2012) Depression in adolescence. Lancet 379:1056–1067CrossRefPubMedPubMedCentral

14.

Power C, Elliott J (2006) Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 35:34–41CrossRefPubMed

15.

Rutter M, Tizard J, Whitmore K (1970) Education, health and behaviour. Longman, Green, London

16.

Rodgers B, Pickles A, Power C, Collishaw S, Maughan B (1999) Validity of the Malaise Inventory in general population samples. Soc Psychiatry Psychiatr Epidimiol 34:333–341CrossRef

17.

Takizawa R, Maughan B, Arsenault L (2014) Adult health outcomes of childhood bullying victimization: evidence from a five-decade longitudinal British birth cohort. Am J Psychiatry 171:777–784CrossRefPubMed

18.

Lewis G, Pelosi AJ, Araya R, Dunn G (1992) Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med 22:465–486CrossRefPubMed

19.

Das-Munschi J, Clark C, Dewey ME, Leavey G, Stansfeld SA, Prince MJ (2013) Does childhood adversity account for poorer mental health and physical health in second-generation Irish people living in Britain? Birth cohort study from Britain (NCDS). BMJ Open 3:e001335CrossRef

20.

Maughan B, Collishaw S, Pickles A (1999) Mild mental retardation: psychosocial functioning in adulthood. Psychol Med 29:351–366CrossRefPubMed

21.

Maughan B, Collishaw S, Stringaris A (2013) Depression in childhood and adolescence. J Can Acad Child Adol Psychiatry 22:35–40

22.

Rutter M, Kim-Cohen J, Maughan B (2006) Continuities and discontinuities in psychopathology between childhood and adult life. J Child Psychol Psychiatry 47:276–295CrossRefPubMed

23.

Stringaris A, Cohen P, Pine DS, Leibenluft E (2009) Adult outcomes of youth irritability: a 20 year prospective community-based study. Am J Psychiatry 166:1048–1054CrossRefPubMedPubMedCentral

24.

Kupfer DJ, Frank E, Phillips MJ (2012) Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 379:1045–1055CrossRefPubMed

25.

Dennerstein L, Soares CN (2008) The unique challenges of managing depression in mid-life women. World Psychiatry 7(3):137–142CrossRefPubMedPubMedCentral

26.

Chang Z, D’Onofrio BM, Quinn PD, Lichtenstein P, Larsson H (2016) Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study. Biol Psychiatry. doi:10.1016/j.biopsych.2016.02.018

27.

Sellers R, Maughan B, Pickles A, Thapar A, Collishaw S (2015) Trends in parent- and teacher-rated emotional, conduct and ADHD problems and their impact in prepubertal children in Great Britain: 1999–2008. J Child Psychol Psychiatry 56:49–57CrossRefPubMed

28.

Stergiakouli E, Martin J, Hamshere ML, Langley K, Evans DM, St Pourcain B et al (2015) Shared genetic influences between attention-deficit/hyperactivity disorder (ADHD) traits in children and clinical ADHD. J Am Acad Child Adolesc Psychiatry 54:322–327CrossRefPubMedPubMedCentral

29.

Collishaw S, Maughan B, Pickles A (2004) Affective problems in adults with mild learning disability: the roles of social disadvantage and ill health. Br J Psychiatry 185:350–351CrossRefPubMed

30.

Young S, Murphy CM, Coghill D (2011) Avoiding the ‘twilight zone’: recommendations for the transition of services from adolescence to adulthood for young people with ADHD. BMC Psychiatry 11:174CrossRefPubMedPubMedCentral

Titel: Childhood hyperactivity and mood problems at mid-life: evidence from a prospective birth cohort
verfasst von: Jenny Stuart-Smith
Anita Thapar
Barbara Maughan
Ajay Thapar
Stephan Collishaw
Publikationsdatum: 22.09.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 1/2017
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-016-1285-5

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

A new era for drinking? Epidemiological evidence on adolescent male–female differences in drinking incidence in the United States and Europe

Epidemiological patterns and correlates of mental disorders among orphans and vulnerable children under institutional care

Psychosocial factors associated with mother–child violence: a household survey

The epidemiology of post-traumatic stress disorder in Norway: trauma characteristics and pre-existing psychiatric disorders